1. Dalal PM. API Text Book of Medicine. Jaypee Brother's Publications, Vol 2, 19th Edition, Ch 20.8, pg 1401, 2012. |
|
2. Cerebrovascular diseases, Ch 34, In: Adam's and Victor's Principles of Neurology, 7th edition, Maurice Victor, Allan Ropper (Eds), McGraw Hill publications, pg 821-919, 2001. |
|
3. Smith WS, English JD, Johnston SC. Cerebrovascular Diseases. In: Harrison's text book of Medicine, 18th edition, vol 2 , Ch 370, pg 3270-3290. |
|
4. Hirsch GA, Vaid N, Blumenthal RS. The Significance of measuring non-HDL Cholesterol. Preventive Cardiology. 2002; 5(3):156-159. [DOI via Crossref] [Pubmed] |
|
5. Goldberg AC. Dyslipidemia (Hyperlipidemia). Merck Manual (Last full review/revision) September 2013. |
|
6. Neurologic complications of hypertension. Ch 7 Anthony S. Kim, Clay Johnston Aminoff's Neurology and General medicine 334:1216, 1996. |
|
7. Stroke fact sheet India. [Accessed 21 July 2013]. http://www.sancd.org/Updated%20Stroke%20Fact%20sheet%202012.pdf. |
|
8. Central Bureau of Health Intelligence. National Health Profile. New Delhi: Directorate General of Health Sci-ences, 2008:102 |
|
9. World Health Organization. Workshop Report on Stroke Surveillance in India. (Last checked 28 June 2012) |
|
10. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G et al. Primary Prevention of Ischemic Stroke: A Statement for Healthcare Professionals from the Stroke Council of the American Heart Association. Circulation. 2001; 103:163 [DOI via Crossref] [Pubmed] |
|
11. Nicholls S and Lundman P. The emerging role of lipoproteins in atherogenesis: beyond LDL cholesterol. Semin Vasc Med. 2004; 4:187-195. [DOI via Crossref] [Pubmed] |
|
12. Wild SH, Byrne CD, Tzoulaki I, et al. Metabolic syndrome, haemostatic and inflammatory markers, Cerebrovascular and peripheral arterial disease: The Edinburgh Artery Study. Atherosclerosis. 2009; 203:604-609. [DOI via Crossref] [Pubmed] |
|
13. Rodriguez-Colon SM, Mo J, Duan Y, et al. Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study. Stroke. 2009; 40:200-205. [DOI via Crossref] [Pubmed] |
|
14. Hirsch GA, Vaid N, Blumenthal RS. The significance of measuring non-HDL cholesterol. Preventive Cardiology. 2002; 5(3): 156-159. [DOI via Crossref] [Pubmed] |
|
15. Jia L, Bai H, Fu M, Xu Y, Yang Y, Long S. Relationship between plasma HDL subclasses distribution and apoA-I gene polymorphisms. Clinica Chimica Acta 2005; 360:37-45. [DOI via Crossref] [Pubmed] |
|
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA. 2001; 285: 2486-97. [DOI via Crossref] |
|
17. Vascular Diseases of the Nervous System Ischemic Cerebrovascular Disease, José Biller, Betsy B. Love, Michael J. Schneck Bradley's neurology in clinical practice 6th edition, vol 1, Elsever Saunders, Ch 51 A,1003-1010. |
|
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA. 2001; 285: 2486-2497. [DOI via Crossref] |
|
19. Cynthia A, Yogeesha KS, et al Dyslipedemia in stroke IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 2014; 13(4):45-49. |
|
20. Sridharan R. Risk factors for ischemic stroke: a case control analysis. Neuroepidemiology.1992; 11:24-30. [DOI via Crossref] [Pubmed] |
|
21. Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth Jr. WT, Psaty BM. Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology. 2004; 63: 1868-1875. [DOI via Crossref] [Pubmed] |
|
22. Xingang Z, Zhaoqing S, Xinzhong Z, Liqiang Z, Shuangshuang L, Changlun X, et al. Gender differences in blood lipids and the risk of ischemic stroke among the hypertensive adults in rural China. Neurology India. 2007; 55:338-3 42. |
|